MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
Wangjie Jiang, Xiao Yang, Kuangheng Shi, Yaodong Zhang, Xiaoli Shi, Jifei Wang, Yuming Wang, Anlan Chenyan, Jijun Shan, Yirui Wang, Jiang Chang, Ruixiang Chen, Tao Zhou, Yan‐Ping Zhu, Yue Yu, Chang Xian Li, Xiangcheng Li
Topics & Concepts
Mad2BiologyCancer researchPI3K/AKT/mTOR pathwayProtein kinase BGemcitabineSpindle checkpointTumor progressionCancerPathologyCell cycle checkpointSignal transductionCell cycleCell biologySpindle apparatusCell divisionCellMedicineGeneticsCholangiocarcinoma and Gallbladder Cancer StudiesRNA modifications and cancerUbiquitin and proteasome pathways